As previously reported, Vertical Research downgraded Solstice Advanced Materials (SOLS) to Hold from Buy with a $90 price target. While stating that Solstice is “off to an exceptionally strong start” in its first six-plus months as a publicly traded company since the spin out of Honeywell (HON) last October, the firm calls the valuation “still reasonable, yet no longer compelling” among specialty chemical companies in its coverage.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLS:
- Solstice Advanced Materials price target raised to $88 from $87 at UBS
- Solstice Advanced Materials price target raised to $85 from $80 at JPMorgan
- Solstice Advanced Materials reports Q1 adjusted EPS 63c, consensus 61c
- Solstice Advanced Materials sees Q2 revenue $1.06B-$1.1B, consensus $1.05B
- Solstice Advanced Materials backs FY26 EPS view $2.45-$2.75, consensus $2.67
